Generic Name and Formulations:
Tetrahydrozoline HCl 0.1%; nasal soln; contains benzalkonium chloride.
Indications for TYZINE:
Adults and Children:
<6yrs: see Contraindications. ≥6yrs: 2–4 drops in each nostril as needed; max: every 3hrs.
Children <6yrs. Concomitant MAO inhibitors.
Do not exceed recommended doses. Cardiovascular disease. Hyperthyroidism. Diabetes. Discontinue if adverse reactions occur. Children. Pregnancy (Cat.C). Nursing mothers.
Hypertensive crisis with MAOIs.
Local effects (eg, burning, stinging, sneezing, dryness of the mucosa), headaches, drowsiness, weakness, tremors, lightheadedness, insomnia, palpitations, rebound congestion.
Soln—15mL (w. dropper)
Psychiatry Advisor Articles
- ADHD, Comorbid Bipolar Disorder Share Similar Neurocognitive Profiles
- Anxiety Prevention Interventions: How Effective Are They?
- Antidepressant Use and Dementia Risk in the Elderly
- No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia
- Sleep Apnea Implant Device Receives FDA Approval
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Physicians Spend Nearly 6 Hours on EHR Tasks Per Day
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Duration of Untreated Depression Predicts Depression Severity
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Cognitive Dysfunction a Sign of Prodromal Parkinson Disease
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Bipolar Depression Benefits From Midday Bright Light Therapy